HITRUST CSF is a certifiable security framework used in healthcare and other sectors. The core assurance portfolio includes e1, i1 and r2. The current publisher portfolio describes e1 as 43 foundational controls; control counts and mappings are version-specific. e1 and i1 certifications last one year; r2 lasts two years with an interim assessment after year one.

Why it matters

HITRUST r2 certification is among the most demanding healthcare security attestations available and is increasingly required by large health systems of their SaaS vendors and connected device manufacturers. The harmonization is the value: a single HITRUST report can satisfy hospital procurement requirements that would otherwise involve separate HIPAA, NIST 800-53, and SOC 2 evidence requests.

Common pitfalls

•e1 and i1 are valid HITRUST certifications. State the certification type, in-scope systems and validity dates rather than implying they are r2.
•Underestimating the cost and timeline, a first-time r2 certification commonly takes 12-18 months and meaningful internal resources.
•Track type-specific validity: e1 and i1 are one-year certifications; r2 is two-year with an interim assessment after year one.

Sources

HITRUST CSF · HITRUST
CISA - Healthcare and Public Health Sector · CISA
FDA - Cybersecurity for Medical Devices · FDA
HITRUST portfolio · HITRUST
HITRUST security-events FAQ · HITRUST

Open full page

Select term B to compare.

Why compare MedTech terms side by side?

MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

Common comparison patterns

Regulatory pathway choice - 510(k) vs PMA, 510(k) vs De Novo, Abbreviated vs Special 510(k).
Quality systems - QSR vs ISO 13485, QMSR vs QSR.
Software classification - SaMD vs SiMD, Locked vs adaptive AI.
EU frameworks - MDR vs IVDR, CE Mark vs UKCA.
Cybersecurity artifacts - SPDX vs CycloneDX SBOM, CVE vs CVSS.
Post-market actions - Recall vs field action, Removal vs correction.

How to use this tool

Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.